FDA Requiring Labeling Changes to NSAIDs Warning of Risks in Pregnancy
Labeling must indicate risks to unborn baby with NSAID use at 20 weeks of pregnancy or later
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.